519 related articles for article (PubMed ID: 33036570)
1. Implications of COVID-19 in high burden countries for HIV/TB: A systematic review of evidence.
Tamuzi JL; Ayele BT; Shumba CS; Adetokunboh OO; Uwimana-Nicol J; Haile ZT; Inugu J; Nyasulu PS
BMC Infect Dis; 2020 Oct; 20(1):744. PubMed ID: 33036570
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Tuberculosis and COVID-19: Lessons from the Past Viral Outbreaks and Possible Future Outcomes.
Crisan-Dabija R; Grigorescu C; Pavel CA; Artene B; Popa IV; Cernomaz A; Burlacu A
Can Respir J; 2020; 2020():1401053. PubMed ID: 32934758
[TBL] [Abstract][Full Text] [Related]
4. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection.
Dinnes J; Deeks JJ; Adriano A; Berhane S; Davenport C; Dittrich S; Emperador D; Takwoingi Y; Cunningham J; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Taylor-Phillips S; Hooft L; Leeflang MM; Spijker R; Van den Bruel A;
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013705. PubMed ID: 32845525
[TBL] [Abstract][Full Text] [Related]
5. Antibody tests for identification of current and past infection with SARS-CoV-2.
Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 and HIV coinfection: clinical experience from Rhode Island, United States.
Byrd KM; Beckwith CG; Garland JM; Johnson JE; Aung S; Cu-Uvin S; Farmakiotis D; Flanigan T; Gillani FS; Macias-Gil R; Mileno M; Ramratnam B; Rybak NR; Sanchez M; Tashima K; Mylonakis E; Kantor R
J Int AIDS Soc; 2020 Jul; 23(7):e25573. PubMed ID: 32657527
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 and tuberculosis: A mathematical model based forecasting in Delhi, India.
Marimuthu Y; Nagappa B; Sharma N; Basu S; Chopra KK
Indian J Tuberc; 2020 Apr; 67(2):177-181. PubMed ID: 32553309
[TBL] [Abstract][Full Text] [Related]
8. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.
Piechotta V; Chai KL; Valk SJ; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD013600. PubMed ID: 32648959
[TBL] [Abstract][Full Text] [Related]
9. A Pandemic within Other Pandemics. When a Multiple Infection of a Host Occurs: SARS-CoV-2, HIV and
González-Domenech CM; Pérez-Hernández I; Gómez-Ayerbe C; Viciana Ramos I; Palacios-Muñoz R; Santos J
Viruses; 2021 May; 13(5):. PubMed ID: 34067925
[TBL] [Abstract][Full Text] [Related]
10. Global prevalence, treatment and outcome of tuberculosis and COVID-19 coinfection: a systematic review and meta-analysis (from November 2019 to March 2021).
Wang Q; Guo S; Wei X; Dong Q; Xu N; Li H; Zhao J; Sun Q
BMJ Open; 2022 Jun; 12(6):e059396. PubMed ID: 35725250
[TBL] [Abstract][Full Text] [Related]
11. Epidemic and pandemic viral infections: impact on tuberculosis and the lung: A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN), and members of the European Society of Clinical Microbiology and Infectious Diseases Study Group for Mycobacterial Infections (ESGMYC).
Ong CWM; Migliori GB; Raviglione M; MacGregor-Skinner G; Sotgiu G; Alffenaar JW; Tiberi S; Adlhoch C; Alonzi T; Archuleta S; Brusin S; Cambau E; Capobianchi MR; Castilletti C; Centis R; Cirillo DM; D'Ambrosio L; Delogu G; Esposito SMR; Figueroa J; Friedland JS; Ho BCH; Ippolito G; Jankovic M; Kim HY; Rosales Klintz S; Ködmön C; Lalle E; Leo YS; Leung CC; Märtson AG; Melazzini MG; Najafi Fard S; Penttinen P; Petrone L; Petruccioli E; Pontali E; Saderi L; Santin M; Spanevello A; van Crevel R; van der Werf MJ; Visca D; Viveiros M; Zellweger JP; Zumla A; Goletti D
Eur Respir J; 2020 Oct; 56(4):. PubMed ID: 32586885
[TBL] [Abstract][Full Text] [Related]
12. It Ain't Over Till It's Over: The Triple Threat of COVID-19, TB, and HIV.
Kay AW; Ness TE; Martinez L; Mandalakas AM
Am J Trop Med Hyg; 2020 Oct; 103(4):1348-1349. PubMed ID: 32876009
[No Abstract] [Full Text] [Related]
13. Tuberculosis and novel Wuhan coronavirus infection: Pathological interrelationship.
Yasri S; Wiwanitkit V
Indian J Tuberc; 2020 Apr; 67(2):264. PubMed ID: 32553324
[TBL] [Abstract][Full Text] [Related]
14. An increasing public health burden arising from children infected with SARS-CoV2: A systematic review and meta-analysis.
Zheng B; Wang H; Yu C
Pediatr Pulmonol; 2020 Dec; 55(12):3487-3496. PubMed ID: 32757374
[TBL] [Abstract][Full Text] [Related]
15. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 disease.
Struyf T; Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Leeflang MM; Spijker R; Hooft L; Emperador D; Dittrich S; Domen J; Horn SRA; Van den Bruel A;
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD013665. PubMed ID: 32633856
[TBL] [Abstract][Full Text] [Related]
16. A comparison of mortality-related risk factors of COVID-19, SARS, and MERS: A systematic review and meta-analysis.
Lu L; Zhong W; Bian Z; Li Z; Zhang K; Liang B; Zhong Y; Hu M; Lin L; Liu J; Lin X; Huang Y; Jiang J; Yang X; Zhang X; Huang Z
J Infect; 2020 Oct; 81(4):e18-e25. PubMed ID: 32634459
[TBL] [Abstract][Full Text] [Related]
17. A 28-Year-Old Man from India with SARS-Cov-2 and Pulmonary Tuberculosis Co-Infection with Central Nervous System Involvement.
Ata F; Yousaf Q; Veliyankodan Parambil J; Parengal J; Mohamedali MG; Yousaf Z
Am J Case Rep; 2020 Aug; 21():e926034. PubMed ID: 32813683
[TBL] [Abstract][Full Text] [Related]
18. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review.
Valk SJ; Piechotta V; Chai KL; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
Cochrane Database Syst Rev; 2020 May; 5(5):CD013600. PubMed ID: 32406927
[TBL] [Abstract][Full Text] [Related]
19. Comorbidity in context: Part 1. Medical considerations around HIV and tuberculosis during the COVID-19 pandemic in South Africa.
Rossouw TM; Boswell MT; Nienaber AG; Moodley K
S Afr Med J; 2020 Jun; 110(7):621-624. PubMed ID: 32880335
[TBL] [Abstract][Full Text] [Related]
20. Treatment of COVID-19 with convalescent plasma: lessons from past coronavirus outbreaks.
Wooding DJ; Bach H
Clin Microbiol Infect; 2020 Oct; 26(10):1436-1446. PubMed ID: 32791241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
